BNGO - Pangali Forward P/E Bionano Genomics

Logo grafis Bionano Genomics, Inc. (BNGO)

Bionano Genomics, Inc. (BNGO) is facing a severe liquidity shortage as expansion costs outpace revenues. Meanwhile, the company is implementing energy-efficient IT solutions and strictly adhering to data privacy. The company's forward P/E ratio visualizes the current market valuation, where the 0.00 parameter determines the metric's magnitude. Fundamental DNA analysis patents create a powerful barrier to entry for competitors.

Rasio rega marang bathi mangsa ngarep: bionanogenomics.com (BNGO) kanggo 04.07.2022 - 16.11.2026

Rincian metrik keuangan lan pasar Bionano Genomics, Inc. (BNGO)

- nilai saham lan prakiraan konsensus rega:
Analisis wiwitan perusahaan:Bionano Genomics
Sampel barang Bionano

The forward P/E reflects the ratio of market capitalization to projected net income, allowing investors to filter out market noise and assess the asset's fundamental value. By analyzing the forward price-to-earnings multiple of Bionano Genomics, Inc. (BNGO), an investor determines the premium paid for future growth, which is critical when scaling Saphyr automated systems and implementing AI-driven DNA analysis to minimize operational errors.

Pesaing Bionano Genomics, Inc. (BNGO)

Prakiraan rega marang bathi TEM (Tempus AI, Inc)|Qiagen Group (QGEN) - Pangali forward rega marang bathi|Rega marang bathi mangsa ngarep ionispharma.com IONS|Kapitalisasi marang proyeksi bathi Repligen Corporation (RGEN)|RNA: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi CRSP (CRISPR Therapeutics Corp)|WGS: Pangali Forward P/E|Rasio prakiraan rega marang bathi Ultragenyx Corp (RARE)|BEAM (Beam Therapeutics Inc) - Pangali Forward P/E|SRPT: Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Twist Bioscience Corp (TWST)|Prakiraan rega marang bathi 10x Genomics Inc TXG|Intellia Therapeutics, Inc. - Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi STOK|BLFS - Rega marang bathi mangsa ngarep|Wave Life Sciences (WVE) - Prakiraan rega marang bathi|MAZE: Pangali Forward P/E|Sionna Therapeutics, Inc. (SION) - Pangali Forward P/E|Rega marang bathi mangsa ngarep Prime Medicine, Inc.|TSHA (Taysha) - Rasio kapitalisasi marang bathi mangsa ngarep|Prakiraan rega marang bathi QURE (uniQure Pharma)|Kapitalisasi marang proyeksi bathi meiragtx.com|Rega marang bathi mangsa ngarep REGENXBIO RGNX|SLDB - Prakiraan rega marang bathi|Ocugen, Inc. - Pangali Forward P/E|PACB (Pacific Biosciences of California) - Rasio rega marang bathi mangsa ngarep|BNTC: Pangali Forward P/E|DSGN - Kapitalisasi marang proyeksi bathi|RCKT (Rocket Pharma) - Pangali Forward P/E|Rega marang bathi mangsa ngarep FDMT|Rega marang bathi mangsa ngarep Lexeo Therapeutics, Inc. (LXEO)|Korro Bio Inc. - Rasio rega marang bathi mangsa ngarep|editasmedicine.com - Prakiraan rega marang bathi|Kapitalisasi marang proyeksi bathi silence-therapeutics.com (SLN)|PRQR: Prakiraan rega marang bathi|Rasio prakiraan rega marang bathi codexis.com|SGMO: Pangali Forward P/E|Rasio prakiraan rega marang bathi Nautilus Biotechnology Inc (NAUT)|Prakiraan rega marang bathi MGX|DTIL (Precision BioSciences) - Rasio kapitalisasi marang bathi mangsa ngarep|Rega marang bathi mangsa ngarep Generation Bio Corp (GBIO)|Boundless Bio - Rasio rega marang bathi mangsa ngarep|Rega marang bathi mangsa ngarep Exicure, Inc. XCUR|Pangali mangsa ngarep rega marang bathi IMNN|PHIO - Rega marang bathi mangsa ngarep|Kapitalisasi marang proyeksi bathi Mustang Bio Inc MBIO|RNAZ: Pangali Forward P/E|Applied DNA Sciences, Inc. (APDN) - Pangali Forward P/E|BLUE (bluebirdbio.com) - Pangali Forward P/E|Rasio rega marang bathi mangsa ngarep IPA (ImmunoPrecise Antibodies)|Pangali Forward P/E OMGA|Prakiraan rega marang bathi Singular Genomics Systems OMIC|Pangali Forward P/E RGLS (regulusrx.com)|Syros Pharmaceuticals Inc. (SYRS) - Rasio prakiraan rega marang bathi|TBIO: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi TCON (TRACON)|UBX: Pangali Forward P/E